Yale launches five-year study of origins of autism
Yale researchers will study the development of functional brain connectivity during late pregnancy to early adolescence thanks to a five-year, $12.4 million grant from Autism Centers of Excellence Program, part of efforts by the National Institutes of Health to understand the origins of autism spectrum disorders (ASD).
New Program Brings Meharry Medical Students into the ‘Yale Family’
Six students were selected from Meharry Medical College, an historically Black medical school in Nashville, in a program designed by Yale School of Medicine’s Office of Diversity, Equity and Inclusion to provide them with research experience and career advancing networking opportunities. The students will work alongside Yale faculty members and residents, begin building networks, and deepen their understanding of careers paths in psychiatry, neurosurgery, and neuroscience.
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
New Drugs on the Horizon for Stroke and Hydrocephalus
Kristopher Kahle, MD, assistant professor of neurosurgery and of cellular and molecular physiology at Yale School of Medicine, recently published a study describing a new compound that could reduce swelling in the brain caused by stroke or hydrocephalus.
Molecular Control of Neurotransmitter Linked to Autism Described
In two new papers published Oct. 15 in Science Signaling, researchers from Yale, France, Japan, and the United Kingdom have zeroed in on a molecular mechanism crucial to normal brain development, which, when impaired, causes autism-like symptoms in mice.
Brain Hemorrhage Surgery Boosts Survival, but Disability Risk Still High
While patients who undergo surgery for intracerebral hemorrhage (ICH) survive at higher rates than those who do not receive surgery, they are also at high risk of significant disability, according to a new Yale-led study published in the journal JAMA.
Brain Tumor Program Hosts Patient Education Event
The Smilow Brain Tumor Program hosted an educational seminar for patients and community providers discussing “A Thoughtful Approach in the Fight Against Brain Tumors: Personalizing Care for the Best Outcomes.” The event featured a welcome with hors d’oeuvres and time to mingle and was generously sponsored by the Lovemark Foundation and supported by the Connecticut Brain Tumor Alliance.
The 3rd Critical Care and Emergency Neuroscience CME Course was held on May 24, 2018 at Yale West Campus.
The 3rd Critical Care and Emergency Neuroscience CME Course was held on May 24, 2018 at Yale West Campus. A collaboration between the Departments of Neurology and Neurosurgery, it attracted 180+ registered participants from across the state (and tri-state region). This year’s theme was Resuscitation of Severe and Traumatic Brain Injury (TBI).
Yale Medicine Facial Pain and Spasm Conference: Providing Multidisciplinary Care and Relief
Our experts, including Drs. Jennifer Moliterno and Jason Gerrard, are specialized in the medical, radiosurgical and surgical management of trigeminal neuralgia and hemifacial spasm, among other pain and movement disorders. They meet regularly with other specialists in Neurology and Radiology to discuss our patients who suffer from these issues, in the most comprehensive manner, to offer relief for each and every patient we care for.
Journal of Vascular Surgery: May 2018 Edition
The May 2018 cover illustration of the Journal of Vascular Surgery is Yale Neurovascular Neurosurgeon, Dr. Charles Matouk's treatment of a symptomatic, cervical ICA pseudoaneurysm that occurred a year ago with overlapping Medtronic Pipeline Flex devices. Great result and innovative strategy!Source: Journal of Vascular Surgery
Yale vascular neurosurgeons the first in Connecticut to repair a complex, wide-neck brain aneurysm using a novel bifurcation device, the PulseRider.
Drs. Ryan Hebert and Charles Matouk (Section Chief of Neurovascular Surgery), working alongside their fellow Branden Cord, performed the first Cerenovus PulseRider® procedure in Connecticut.